An Open Study to Investigate the Safety and Efficacy of Replenine®-VF in Severe Haemophilia B Patients

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

July 31, 1997

Primary Completion Date

October 31, 2003

Conditions
Haemophilia B
Interventions
BIOLOGICAL

Replenine®-VF (High Purity Factor IX)

Trial Locations (7)

Unknown

Klinika Hematologii Instytutu Medycyny Wewnetrznej, Lodz

Klinika Hematologii AM Lublin, ul.Jaczewskiego 8, Lublin

Addenbrooke's Hospital, Hills Road, Cambridge

University Hospital of Wales, Heath Park, Cardiff

The Royal London Hospital, London

Manchester Royal Infirmary, Oxford Road, Manchester

Norwich and Norfolk Hospital, Norwich

Sponsors
All Listed Sponsors
lead

Bio Products Laboratory

OTHER